A major step in Binance's vision to build a multi-asset financial super app for investing, trading, and on-chain finance

ABU DHABI, UAE, June 1, 2026 /PRNewswire/ -- Binance today introduced U.S. equities trading, giving eligible users access to more than 7,000 U.S.-listed stocks and ETFs. The launch reflects Binance's belief that financial inclusion grows meaningfully when access to opportunities becomes simpler and more integrated. Binance will also soon introduce tokenized U.S. stocks, marking another step in its vision of a multi-asset financial super app.

"We have set out to reach the next 3 billion users, and to do that, we need to make it simpler for users to access opportunities across asset classes, diversify their portfolios, and move more easily between traditional investing and on-chain finance," said Yi He, co-founder and co-CEO of Binance. "That is what a multi-asset financial super app should help people do."

Enabled through Binance's ADGM broker-dealer, Nest Trading Limited, the new offering expands Binance's multi-asset platform by bringing U.S. equities trading and a path to tokenization into a unified user experience. By reducing friction around how users access and hold major traditional assets, Binance is building on an approach already proven in products like perpetual futures.

Eligible users will be able to trade U.S. equities with zero commission, purchase fractional shares starting at just $5, and have direct ownership of the equities held by a U.S.-regulated clearing broker, including eligibility for applicable dividends and corporate actions. Select equities will also be available for 24/5 trading. Purchases will primarily be made using USDC, with support for BNB, USDT, USD1, and $U, and sale proceeds will be received in USDC. Fully Paid Securities Lending (FPSL) will be available, allowing eligible users to earn passive income by lending their stock holdings.

In the coming weeks and subject to regulatory approvals, Binance will also introduce bStocks, tokenized securities representing select U.S. stocks and ETFs, issued by BTECH Holdings Ltd, a Special Purpose Vehicle (SPV) registered in the Abu Dhabi Global Market (ADGM). Once launched, bStocks tokenized securities will be available for trading on Binance Exchange.

As the largest digital assets exchange by trading volume and users, Binance will offer a native bridge from traditional stock ownership to programmable, always-on tokenized assets at a global scale that few others can match. This unlocks mobility and utility for real-world equities within and beyond the Binance ecosystem, enabling continuous on-chain access and potential DeFi applications, from lending to liquidity provision.

"Tokenization has the potential to reshape financial markets by giving users greater control, more flexibility, and ultimately more financial freedom," said Richard Teng, co-CEO of Binance. "We see a significant opportunity to make financial assets more accessible, more useful, and more connected across traditional and digital markets."

# # #

Important notes:

1. This announcement is jointly made by Nest Trading Limited and Nest Exchange Limited.
   
   
   
   
2. Nest Trading Limited acts as your introducing broker and routes your orders for Securities to its clearing broker partner, Alpaca, for execution, clearing, settlement and custody. Binance does not handle or custody your Securities. Securities are subject to high market and liquidity risk and price volatility (particularly outside traditional market hours).
   
   
   
   
3. bStocks are not stocks or shares and bStocks do not allow holders to directly own a share or stock in the underlying listed company. bStocks Tokenized Securities are classified as Certificates representing certain Financial Instruments (paragraph 92, Schedule 1 to FSMR).  
   
   
   
   
4. The issuance of bStocks tokenized securities is subject to regulatory approval by the FSRA.
   
   
   
   
5. This announcement is for general information only and is not an offer, solicitation, recommendation, or invitation to buy or sell securities in any jurisdiction. The offering is available only to eligible users in permitted jurisdictions.
   
   
   
   
6. Binance does not onboard or service U.S. persons. bStocks are not offered, sold, distributed, made available, or accessible in the United States or to, or for the account or benefit of, U.S. persons. bStocks have not been registered under the U.S. Securities Act of 1933 or any U.S. state securities laws.
   
   
   
   
7. bStocks are subject to market risk, liquidity risk, issuer risk, custody risk, broker risk, operational risk, technology risk, regulatory risk, tax risk, fees, withholding, transfer restrictions, and possible loss of the entire investment. Users should read the applicable Prospectus, Terms of Use, Securities Trading Product Terms, bStocks Minting and Redemption Product Terms, Risk Warning, Exchange Rules, and Exchange Procedures before trading.

About Binance

Binance is a leading global blockchain ecosystem behind the world's largest cryptocurrency exchange by trading volume and registered users. Binance is trusted by more than 310 million people in 100+ countries for its industry-leading security, transparency, trading engine speed, protections for investors, and unmatched portfolio of digital asset products and offerings from trading and finance to education, research, social good, payments, institutional services, and Web3 features. Binance is devoted to building an inclusive crypto ecosystem to increase the freedom of money and financial access for people around the world with crypto as the fundamental means. For more information, visit: https://www.binance.com.

Logo - https://mma.prnewswire.com/media/1773650/5996949/Binance_Logo_Yellow_4x_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/binance-launches-us-stocks-trading-and-previews-bstocks-tokenized-securities-302787238.html

Sandoz hat im ersten Quartal 2026 trotz erheblicher Verwerfungen im Penicillin-Geschäft weiteres Wachstum erzielt. Der Umsatz des Schweizer Generika- und Biosimilar-Spezialisten belief sich zwischen Januar und März auf 2,76 Milliarden US-Dollar, ein Plus von 11 Prozent gegenüber dem Vorjahreszeitraum. Zu konstanten Wechselkursen legten die Erlöse um 3 Prozent zu. Der Konzern bestätigt nach eigenen Angaben seinen Ausblick für das Gesamtjahr.

Treiber der Entwicklung war vor allem das höhermargige Biosimilar-Geschäft, das die frühere Novartis-Tochter weiter ausgebaut hat. Dagegen stand die grössere Generika-Sparte erneut unter Druck, weil sich die Marktverwerfungen im Penicillin-Segment fortsetzten. Klammerte man die negativen Auswirkungen aus dem Antibiotika-Geschäft aus, hätte das Umsatzplus zu konstanten Wechselkursen bei rund 5 Prozent gelegen und damit im Rahmen der Unternehmensprognose.

Die Belastungen resultieren aus einem anhaltenden Preisverfall bei wichtigen Penicillin-Wirkstoffen (Active Pharmaceutical Ingredients), der bereits im Vorjahr eingesetzt hatte. Hintergrund sind US-Zölle, die chinesische Anbieter dazu veranlasst haben, ihre Penicillin-Mengen verstärkt nach Europa umzuleiten. Das zusätzliche Angebot hat dort die Preise deutlich gedrückt. Parallel dazu führten in Indien eingeführte Mindestpreisvorschriften dazu, dass weniger chinesische Ware in diesen Markt floss, was den Wettbewerbsdruck in Europa zusätzlich verschärfte und den Preisdruck weiter verstärkte.

Laut Sandoz konzentrieren sich die heftigsten Auswirkungen dieser Entwicklung auf das erste Quartal, die verbleibenden Effekte sollen sich nun schrittweise abschwächen. Analysten verweisen darauf, dass das Unternehmen ohne den Antibiotika-Gegenwind im Rahmen seiner Guidance gewachsen wäre. Der Konzern bleibt damit auf Wachstumskurs, muss sich im Generika-Kerngeschäft jedoch weiterhin in einem von handelspolitischen Eingriffen und regulatorischen Änderungen verzerrten Marktumfeld behaupten.